| 36935288 | Cellular and humoral responses to an HIV DNA prime by electroporation boosted with recombinant vesicular stomatitis virus expressing HIV subtype C Env in a randomized controlled clinical trial. | Vaccine | 2023 |
| 37795976 | Protein dose-sparing effect of AS01B adjuvant in a randomized preventive HIV vaccine trial of ALVAC-HIV (vCP2438) and adjuvanted bivalent subtype C gp120. | J Infect Dis | 2023 |
| 37609144 | Plasma Glycomic Markers of Accelerated Biological Aging During Chronic HIV Infection. | bioRxiv | 2023 |
| 37300931 | Pharmacokinetic serum concentrations of VRC01 correlate with prevention of HIV-1 acquisition. | EBioMedicine | 2023 |
| 36877848 | HIV post-treatment controllers have distinct immunological and virological features. | Proc Natl Acad Sci U S A | 2023 |
| 35192740 | A retrospective study of HIV pre-exposure prophylaxis counselling among non-Hispanic Black youth diagnosed with bacterial sexually transmitted infections in the United States, 2014-2019. | J Int AIDS Soc | 2022 |
| 35536669 | A phase I trial of cyclosporine for hospitalized patients with COVID-19. | JCI Insight | 2022 |
| 35687192 | Sexual behavior and medication adherence in men who have sex with men participating in a pre-exposure prophylaxis study of combinations of Maraviroc, Tenofovir Disoproxil Fumarate and/or Emtricitabine (HPTN 069/ACTG 5305). | AIDS Behav | 2022 |
| 35848549 | Altered adipose tissue macrophage populations in people with HIV on integrase inhibitor-containing antiretroviral therapy. | AIDS | 2022 |
| 36136590 | Lower SARS-CoV-2-specific humoral immunity in people living with HIV-1 recovered from nonhospitalized COVID-19. | JCI Insight | 2022 |
| 36380851 | Using a patient portal as a recruitment tool to diversify the pool of participants in COVID-19 vaccine clinical trials. | JAMIA Open | 2022 |
| 36351430 | Nucleocapsid-specific antibody function is associated with therapeutic benefits from COVID-19 convalescent plasma therapy. | Cell Rep Med | 2022 |
| 36261003 | SARS-CoV-2 infections elicit higher levels of original antigenic sin antibodies compared with SARS-CoV-2 mRNA vaccinations. | Cell Rep | 2022 |
| 35145311 | Initial analysis of viral dynamics and circulating viral variants during the mRNA-1273 Phase 3 COVE trial. | Nat Med | 2022 |
| 32860114 | Mental Health, Social Influences, and HIV Pre-exposure Prophylaxis (PrEP) Utilization Among Men and Transgender Individuals Screening for HIV Prevention Trials. | AIDS Behav | 2021 |
| 33907765 | Sero-monitoring of health care workers reveals complex relationships between common coronavirus antibodies and SARS-CoV-2 severity. | medRxiv | 2021 |
| 33730454 | Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition. | N Engl J Med | 2021 |
| 33587505 | Feasibility and Successful Enrollment in a Proof-of-Concept HIV Prevention Trial of VRC01, a Broadly Neutralizing HIV-1 Monoclonal Antibody. | J Acquir Immune Defic Syndr | 2021 |
| 33887209 | Safety and immunogenicity of SARS-CoV-2 recombinant protein vaccine formulations in healthy adults: interim results of a randomised, placebo-controlled, phase 1-2, dose-ranging study. | Lancet Infect Dis | 2021 |
| 33831911 | Higher colorectal tissue HIV infectivity in cisgender women compared with MSM before and during oral preexposure prophylaxis. | AIDS | 2021 |
| 34871308 | Neutralizing antibody responses over time in demographically and clinically diverse individuals recovered from SARS-CoV-2 infection in the United States and Peru: A cohort study. | PLoS Med | 2021 |
| 34648302 | mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern. | Science | 2021 |
| 34379922 | Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women. | N Engl J Med | 2021 |
| 34551263 | Effects of a Health Promotion Intervention on Physical Activity in African American Men Living with HIV: Randomized Controlled Trial. | AIDS Patient Care STDS | 2021 |
| 34788233 | A randomized controlled study of convalescent plasma for individuals hospitalized with COVID-19 pneumonia. | J Clin Invest | 2021 |
| 34462751 | mRNA Vaccination Induces Durable Immune Memory to SARS-CoV-2 with Continued Evolution to Variants of Concern. | bioRxiv | 2021 |
| 34459907 | Racial/Ethnic Differences in COVID-19 Vaccine Hesitancy Among Health Care Workers in 2 Large Academic Hospitals. | JAMA Netw Open | 2021 |
| 34237028 | Health care worker seromonitoring reveals complex relationships between common coronavirus antibodies and COVID-19 symptom duration. | JCI Insight | 2021 |
| 34086344 | Identification of the predominant human NK cell effector subset mediating ADCC against HIV-infected targets coated with BNAbs or plasma from PLWH. | Eur J Immunol | 2021 |
| 34166231 | Rectal tissue and vaginal tissue from intravenous VRC01 recipients show protection against ex vivo HIV-1 challenge. | J Clin Invest | 2021 |
| 33972943 | Signaling through FcγRIIA and the C5a-C5aR pathway mediates platelet hyperactivation in COVID-19. | bioRxiv | 2021 |
| 34081073 | Effect of Bamlanivimab vs Placebo on Incidence of COVID-19 Among Residents and Staff of Skilled Nursing and Assisted Living Facilities: A Randomized Clinical Trial. | JAMA | 2021 |
| 33400589 | Prior Sexually Transmitted Infection and Human Immunodeficiency Virus Risk Perception in a Diverse At-Risk Population of Men Who Have Sex with Men and Transgender Individuals. | AIDS Patient Care STDS | 2021 |
| 33449236 | HIV Infection and Depression Among Opiate Users in a US Epicenter of the Opioid Epidemic. | AIDS Behav | 2021 |
| 32895573 | Recommendations for measuring HIV reservoir size in cure-directed clinical trials. | Nat Med | 2020 |
| 33239444 | Autologous IgG antibodies block outgrowth of a substantial but variable fraction of viruses in the latent reservoir for HIV-1. | Proc Natl Acad Sci U S A | 2020 |
| 30399039 | Brief Report: Rate of Nicotine Metabolism and Tobacco Use Among Persons With HIV: Implications for Treatment and Research. | J Acquir Immune Defic Syndr | 2019 |
| 31533030 | Mapping the Lineage Relationship between CXCR5<sup>+</sup> and CXCR5<sup>-</sup> CD4<sup>+</sup> T Cells in HIV-Infected Human Lymph Nodes. | Cell Rep | 2019 |
| 31434737 | Fc Gamma Receptor Polymorphisms Modulated the Vaccine Effect on HIV-1 Risk in the HVTN 505 HIV Vaccine Trial. | J Virol | 2019 |
| 31566579 | DNA priming and gp120 boosting induces HIV-specific antibodies in a randomized clinical trial. | J Clin Invest | 2019 |
| 31082665 | Placebo-controlled randomized clinical trial testing the efficacy and safety of varenicline for smokers with HIV. | Drug Alcohol Depend | 2019 |
| 28744666 | Lessons for Patient Education Around Long-Acting Injectable PrEP: Findings from a Mixed-Method Study of Phase II Trial Participants. | AIDS Behav | 2018 |
| 29858286 | Identification and characterization of HIV-specific resident memory CD8<sup>+</sup> T cells in human lymphoid tissue. | Sci Immunol | 2018 |
| 30235286 | Safety and tolerability of HIV-1 multiantigen pDNA vaccine given with IL-12 plasmid DNA via electroporation, boosted with a recombinant vesicular stomatitis virus HIV Gag vaccine in healthy volunteers in a randomized, controlled clinical trial. | PLoS One | 2018 |
| 30445896 | Satisfaction and acceptability of cabotegravir long-acting injectable suspension for prevention of HIV: Patient perspectives from the ECLAIR trial. | HIV Clin Trials | 2018 |
| 29669853 | CD32 is expressed on cells with transcriptionally active HIV but does not enrich for HIV DNA in resting T cells. | Sci Transl Med | 2018 |
| 29667531 | Is Tobacco Use Associated with Neurocognitive Dysfunction in Individuals with HIV? | J Int Assoc Provid AIDS Care | 2018 |
| 29370030 | BETA-D-GLUCAN TESTING IN PATIENTS WITH FUNGAL ENDOPHTHALMITIS. | Retina | 2018 |
| 29325070 | Modification of the Association Between T-Cell Immune Responses and Human Immunodeficiency Virus Type 1 Infection Risk by Vaccine-Induced Antibody Responses in the HVTN 505 Trial. | J Infect Dis | 2018 |
| 27811319 | Phase 2 Study of the Safety and Tolerability of Maraviroc-Containing Regimens to Prevent HIV Infection in Men Who Have Sex With Men (HPTN 069/ACTG A5305). | J Infect Dis | 2017 |